Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference
Andrew A. House(Western University), Peter A. McCullough(Providence Hospital), G. Sheinfeld(University of Maryland, College Park), Ilona Bobek, Sachin Soni(MaxCure Hospitals), Andrew Shaw, Piotr Ponikowski(Wroclaw Medical University), Nadia Aspromonte(Agostino Gemelli University Polyclinic), Mikko Haapio(Helsinki University Hospital), Tomás Berl(University of Colorado Health), Giorgio Vescovo(Ospedale San Bortolo), Sunil Mankad(Mayo Clinic in Arizona), D. Cruz(Ospedale San Bortolo), Hans L. Hillege(University Medical Center Groningen), Sean M. Bagshaw(University of Alberta), Alberto Palazzuoli, Alan S. Maisel(University of California San Diego Medical Center), Luciano Daliento(University of Padua), Nereo Zamperetti(Ospedale San Bortolo), Claudio Ronco(International Renal Research Institute of Vicenza), S. D. Anker(Charité - Universitätsmedizin Berlin), Alexandre Mebazaa, P. Zanco(Ospedale San Bortolo), Abigail Davenport(UCL Australia), Federico Ronco(University of Padua), R. Bellomo(The University of Melbourne), Inder S. Anand(University of Minnesota), N. Katz(George Washington University)
Cited by 146
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
|European Journal of Heart Failure|2016|5.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
The Seattle Heart Failure Model
|Circulation|2006|2k